issue

May 4, 2026

Volume 22 Number 9

In this issue of EuroIntervention, we bring you a State-of-the-Art review on slow flow and no reflow; a Viewpoint on intracoronary imaging and drug-coated balloon treatment; Original Research on the 2-year outcomes of FAVOR III Europe; Original Research on predicting changes in coronary plaque burden by IVUS; a Research Correspondence on drug-coated balloons for CABG failure; a Flashlight on plaque redistribution after DCB angioplasty; and more...

Viewpoint

Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N, Gonzalo N, Neylon A, Alfonso F
10.4244/EIJ-D-25-01066
free

State-of-the-Art

Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S, Ortega-Paz L, Gomez-Lara J, Laudani C, Strosio M, Sabaté M
10.4244/EIJ-D-25-01346
free

Original Research

Quantitative flow ratio versus fractional flow reserve: 2-year follow-up of the FAVOR III Europe trial
Andersen B, Holm N, Sejr-Hansen M, Erriquez A, Råmunddal T, Stähli B, Guiducci V, Mogensen L, Westra J, Escaned J, Christiansen E, of the FAVOR III Europe investigators o
10.4244/EIJ-D-25-01255

Editorial comment

Expanding physiology beyond the wire: will 2026 be the defining year?
Campo G, Biscaglia S
10.4244/EIJ-D-26-00289
free
Derivation and external validation of a deep learning model to predict changes in coronary plaque burden
Garcia-Garcia H, Bulant C, Boroni G, Clausse A, Engstrøm T, Lemos P, Lecaros Yap N, Cap M, Iglesias J, Geuns R, Lang I, Spirk D, Häner J, Koskinas K, Kakizaki R, Ueki Y, Siontis G, Bourantas C, Blanco P, Räber L
10.4244/EIJ-D-25-01352

Research Correspondence

Drug-coated balloons for the treatment of coronary artery bypass graft failure
Marschall A, Chavez-Solsol J, Gonzalo N, Rivero F, Salinas P, Díez Del Hoyo F, Mejía-Rentería H, Escaned J, Alfonso F, Macaya-Ten F
10.4244/EIJ-D-25-01273

Flashlight

Natural history of coronary plaque redistribution after drug-coated balloon angioplasty
Dobrolińska M, Skorupski W, Kruk M, Dey D, Opolski M
10.4244/EIJ-D-25-01145

Receive our newsletter

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved